FdaApplication

ANDA 209697

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTORRENT PHARMA INC
application_typeANDA
approval_date2024-04-04

Products (2)

ProductActive ingredientStrengthDosage form
TERIFLUNOMIDETERIFLUNOMIDE7MGTABLET;ORAL
TERIFLUNOMIDETERIFLUNOMIDE14MGTABLET;ORAL

2 products